A recent Consumer Trends Tracker by dunnhumby reveals a seismic shift in U. S. shopping habits driven by financial strai...
Read More
A recent Consumer Trends Tracker by dunnhumby reveals a seismic shift in U. S. shopping habits driven by financial strai...
Read More
Allegis Global Solutions snagged ClearlyRated's 2026 Best of HR Services Award on February 18, claiming a victory that p...
Read More
Wingstop (NASDAQ:WING) hit the scene on February 18, 2026, reporting its Q4 earnings with a solid surprise that sent tra...
Read More
Moodys (NYSE:MCO) dropped its Q4 earnings report on February 18, 2026. And let me tell you—the desks were buzzing righ...
Read More
Onward FX kicked off its latest venture capital push in Bentonville, Arkansas on February 18, 2026. This program's alrea...
Read More
Halozyme's Participation in Major Healthcare Conference Halozyme Therapeutics, Inc. (NASDAQ: HALO) is set to showcase its advancements at an important healthcare conference. Dr. Helen Torley, the president and CEO, will present and engage in investor meetings, highlighting the company's innovative approaches in the biopharmaceutical sector. Details of the Presentation The...
Continue Reading
Emerging Markets Adjust with Record Bond Sales Amid economic uncertainty, borrowers in developing regions are intensifying their efforts to navigate potential market turbulence, particularly due to significant fluctuations influenced by US economic conditions. Authorities and businesses have proactively begun securing funds through bond sales, reflecting a strategic move...
Continue Reading
Multi Ways Holdings Limited Reports on Financial Results Multi Ways Holdings Limited (NYSE American: MWG), a prominent provider of heavy construction equipment, has recently shared its financial outcomes for the fiscal year 2024. With a focus on innovation and customer satisfaction in Singapore and neighboring regions, the company continues to adapt to the dynamic market...
Continue Reading
Neurocrine Biosciences Shifts Strategy After Luvadaxistat Trial Neurocrine Biosciences Inc. (NASDAQ: NBIX) has made revisions to its strategic approach following the outcomes of the ERUDITE phase two clinical trial involving luvadaxistat (NBI-1065844). This investigational treatment aimed at addressing cognitive impairment in schizophrenia did not achieve its primary...
Continue Reading
Rinnai America Takes Action Against DOE Regulations Rinnai America Corporation, a prominent manufacturer of noncondensing tankless water heaters, has joined forces with 21 state attorneys general and various business groups to challenge the recent final rule issued by the U.S. Department of Energy (DOE) concerning consumer tankless water heaters. This action follows a...
Continue Reading